A two-decade bibliometric analysis of drug resistance in oral cancer research: patterns, trends, and future directions
Open Access
- 1 April 2025
- journal article
- research article
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-20
Abstract
Background Drug resistance in oral cancer presents a significant challenge in clinical treatment. Understanding the research landscape through bibliometric analysis can provide valuable insights into the development and trends in this field. Objective To comprehensively analyze the global research trends, collaboration patterns, and emerging topics in oral cancer drug resistance research from 2000 to 2024 using bibliometric methods. Methods Publications related to oral cancer drug resistance were retrieved from the Web of Science core collection database. CiteSpace and VOSviewer were employed to analyze publication trends, research collaboration networks, and keyword co-occurrence patterns. The analysis included annual publication outputs, country contributions, institutional productivity, author collaborations, journal distributions, and research hotspots. Results A total of 971 publications were identified, showing a significant increase in research output over the study period, particularly after 2014. China led in publication output (485 articles), followed by Japan (130 articles) and the United States (118 articles). China Medical University was the most productive institution (50 publications). The International Journal of Molecular Sciences, Cancers, and Oral Oncology were the primary publishing venues. Keyword analysis revealed an evolution from basic drug resistance mechanisms to emerging research areas including cancer stem cells, tumor microenvironment, and extracellular vesicles. Conclusions This bibliometric analysis demonstrates the rapid growth and evolving nature of oral cancer drug resistance research. The findings highlight the shift towards more sophisticated research areas and strong international collaboration patterns. These insights can guide future research directions and collaboration opportunities in this field.Keywords
Funding Information
- Science and Technology Key Project of Quzhou City (2022K48, 2022K48)
This publication has 45 references indexed in Scilit:
- Overview of Evidence-Based Chemotherapy for Oral Cancer: Focus on Drug Resistance Related to the Epithelial-Mesenchymal TransitionBiomolecules, 2021
- Hedgehog signaling promotes multidrug resistance by regulation of ABC transporters in oral squamous cell carcinomaJournal of Oral Pathology & Medicine, 2020
- Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell CarcinomaInternational Journal of Molecular Sciences, 2019
- Multidrug resistant tumors-aimed theranostics on the basis of strong electrostatic attraction between resistant cells and nanomaterialsBiomaterials Science, 2019
- Cisplatin-Resistance in Oral Squamous Cell Carcinoma: Regulation by Tumor Cell-Derived Extracellular VesiclesCancers, 2019
- Celastrol induces vincristine multidrug resistance oral cancer cell apoptosis by targeting JNK1/2 signaling pathwayPhytomedicine, 2019
- Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatmentInternational Journal of Nanomedicine, 2017
- Multidrug resistance and tumor-initiating capacity of oral cancer stem cells.2016
- The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinomaBMC Cancer, 2009
- [p53 mutation and chemoresistance in oral-maxillofacial squamous cell carcinoma. Role of p53 in the cell cycle control and in the modulating action of chemotherapeutic agents].1997